loader2
Partner With Us NRI

Alembic Pharmaceuticals Ltd share Price Today

Company details

954.25
1,009.55
542.40
1,094.00
6M Return 32.88%
1Y Return 70.54%
Mkt Cap.(Cr) 19,176.69
Volume 1,98,396
Div Yield 1.13%
OI
-
OI Chg %
-
Volume 1,98,396
NSE

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started

Pharmaceuticals company Alembic Pharmaceuticals announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Net Sales increased 8% to Rs 1,517 crore.
  • Net Profit up 17% to Rs 178 crore
  • EBITDA up 29% to Rs 263 crore

FY24 Financial Highlights:

  • Net Sales grew 10% to Rs 6,229 crore.
  • Net Profit up 80% to Rs 616 crore
  • EBITDA up 41% to Rs 961 crore. 

Shaunak Amin, MD, Alembic Pharmaceuticals said “India Branded Business continues to work on improving the execution ability both in quality & scale. The Specialty and Animal health segment witnessed robust growth. The outlook for the US business appears better, with the commercialization of new facilities and launches set to scale up along with continued progress in achieving cost improvements. The Ex-US generics and the API business maintained a steady continuous growth.”

Result PDF

View Other Company Results

Alembic Pharmaceuticals Ltd shares SWOT Analysis

Strengths (7)

  • Strong Annual EPS Growth
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Company with Low Debt

Weakness (1)

  • Decline in Net Profit (QoQ)

Opportunity (0)

Data not found

Threats (1)

  • Increasing Trend in Non-Core Income
Discover More

Resistance and support

R1 1,005.4
R2 1,035.1
R3 1,060.7
Pivot

979.80

S1 950.1
S2 924.5
S3 894.8
EMA SMA
991.3
978.3
938.0
862.3
983.0
988.1
942.4
851.1
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-10-11 611.25 184251 BSE
ISHARES MSCI INDIA SMALL-CAP ETF Block Purchase 2022-10-11 611.25 25903 BSE
ISHARES CORE EMERGING MARKETS MAURITIUS CO Block Sell 2022-10-11 611.25 184251 BSE
Discover More
Name Category Shares
Chirayu Ramanbhai Amin PROMOTER 2.13%
Malika Chirayu Amin PROMOTER 1.53%
Pranav Chirayu Amin PROMOTER 0.51%
Shaunak Chirayu Amin PROMOTER 0.51%
Nirayu Limited PROMOTER 35.63%
Alembic Limited PROMOTER 28.54%
Udit Chirayu Amin PROMOTER 0.51%

OUR RESEARCH VIEW

Investment recommendation
Report Test
Call Date
03 May 2022
Entry Price 725.00
Target Price 720.00
Duration
12-18 Month
HOLD
DISCOVER MORE

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Alembic Pharmaceuticals Ltd Stocks COMPARISON

Financials( ₹ in Cr) Alembic Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 975.60 1,506.55 1,339.55 3,793.50 982.15
% Change -2.57 0.80 -1.42 0.09 1.44
Mcap ₹ Cr 19,176.69 3,61,471.81 1,08,150.85 1,00,705.67 98,827.27
Revenue TTM ₹ Cr 5,652.62 43,885.68 22,753.12 7,767.51 17,237.40
Net Profit TTM ₹ Cr 341.99 8,560.84 2,835.49 1,823.38 1,997.30
PE TTM 31.11 38.52 25.40 72.78 29.65
1 Year Return 70.54 57.35 42.63 12.13 87.09
ROCE 7.20 16.79 17.79 19.30 16.25
ROE 7.12 16.46 12.82 14.89 14.05
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 4,370.47 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 40,292.52 -39,101.37
LAST 3M 97,195.39 -16,897.62
LAST 6M 1,59,485.99 61,690.63
LAST 12M 2,49,857.63 1,46,087.29
Alembic Pharmaceuticals Limited - Outcome of Board Meeting

May 10, 2024 l NSE Announcement

Alembic Pharmaceuticals receives USFDA approval for various products

May 09, 2024 l BSE Announcement

Alembic Pharmaceuticals Limited - Dividend

May 09, 2024 l NSE Announcement

DISCOVER MORE
Date Action Type Ratio
Jul 28, 2023 Dividend 400
Aug 17, 2022 Dividend 500
DISCOVER MORE

Alembic Pharmaceuticals Ltd Information

Stock PE (TTM)
31.11
Promoter Holding
69.61%
Book Value
245.1224
ROCE
7.2%
ROE
7.12%
Registered Address

Alembic Road, , Vadodara, Gujarat, 390003

Tel : 91-0265-2280550
Email : apl.investors:alembic.co.in
Website : http://www.alembic-india.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 533573
NSE Code : APLLTD
Book Closure Date (Month) :
BSE Group : A
ISIN : INE901L01018

FAQ’s on Alembic Pharmaceuticals Ltd Shares

You can buy Alembic Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Alembic Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 10, 2024 03:56 PM the closing price of Alembic Pharmaceuticals Ltd was Rs.975.60.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 10, 2024 03:56 PM, the market cap of Alembic Pharmaceuticals Ltd stood at Rs. 19,176.69.

The latest PE ratio of Alembic Pharmaceuticals Ltd as of May 10, 2024 03:56 PM is 31.11

The latest PB ratio of Alembic Pharmaceuticals Ltd as of May 10, 2024 03:56 PM is 0.25

The 52-week high of Alembic Pharmaceuticals Ltd share price is Rs. 1,094.00 while the 52-week low is Rs. 542.40

According to analyst recommendations, Alembic Pharmaceuticals Ltd Share has a "Buy" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started
Open a Trading Account